U.S. markets closed

Fresenius Medical Care AG (FMS)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
19.28-0.08 (-0.41%)
Al cierre: 04:00PM EDT
19.68 +0.40 (+2.07%)
Fuera de horario: 05:59PM EDT

Fresenius Medical Care AG

Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com

Sector(es)Healthcare
IndustriaMedical Care Facilities
Empleados a tiempo completo119,845

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Ms. Helen GizaCEO & Chair of Management Board of Fresenius Med. Care Mgmt AG5.34MN/D1968
Mr. Martin FischerCFO & Member of the Management Board of Fresenius Medical Care Management AG960.78kN/D1977
Dr. Franklin W. Maddux F.A.C.P.Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG3MN/D1957
Dr. Katarzyna Mazur-Hofsab Ph.D.Management Board Member for Care Enablement of Fresenius Medical Care Management AG3.12MN/D1963
Mr. Craig Cordola FACHE, M.B.A., M.H.A.CEO of Care Delivery & Member of Management BoardN/DN/D1970
Dr. Dominik HegerExecutive VP and Head of Investor Relations, Strategic Development & CommunicationsN/DN/DN/D
Mr. Joachim WeithSenior Vice President of Corporate Communications & Governmental AffairsN/DN/DN/D
Dr. Gail-Suzanne BrownSenior Vice President of Research & DevelopmentN/DN/DN/D
Mr. Glenn SlaterSenior Vice President of Manufacturing and Supply Chain OperationsN/DN/DN/D
Dr. Wolfgang KummerleSenior Vice President - Quality Management InternationalN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Gestión corporativa

La calificación ISS Governance QuickScore de Fresenius Medical Care AG a partir del 1 de marzo de 2024 es 8. Las puntuaciones principales son Auditoría: 3; Junta: 7; Derechos del accionista: 1; Compensación: 9.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.